Basem Yazgi Takes Over STADA’s Generics Business
Basem Yazgi has taken over leadership of STADA’s generics business in Germany. As the new General Manager of ALIUD PHARMA, he succeeds Melania Pahor.
Image: STADA Consumer Health & STADAPHARM GmbH
Germany strengthens WHO with €10 million
Germany supports the WHO with €10 million, sending a clear message for global health and international cooperation in pandemic response.
BPI at Ludwig Erhard Summit 2025: Health Needs Innovation
At the 2025 Ludwig Erhard Summit, BPI delivered a strong call for innovation-driven healthcare and advocated for the pharmaceutical SME sector.
Tobias Brodtkorb Joins HERMES ARZNEIMITTEL as Co-CEO
Starting July 1, Tobias Brodtkorb will join HERMES ARZNEIMITTEL as Co-CEO, forming a new leadership duo with Thomas Stadler to drive the company’s continued growth.
AI in Healthcare: Majority Sees Opportunity
A recent Deloitte survey reveals that most insured individuals in Germany see clear benefits in using AI in healthcare. Younger generations especially expect improved treatment quality and more time for doctor-patient communication.
AMIE Gets Vision: Medical AI Goes Multimodal
AMIE, Google’s medical research AI, gains the ability to analyze medical images during diagnostic conversations. A new study shows it can even outperform physicians.
Bertelsmann Investments Acquires Docuvera
Bertelsmann Investments stärkt seine Pharma-Tech-Einheit cormeo durch die vollständige Übernahme von Docuvera – einem Pionier für KI-gestützte Content-Lösungen in der Life-Sciences-Branche.
Health Policy in the Spotlight: German Medical Assembly in Leipzig
The 129th German Medical Assembly is bringing healthcare policy to Leipzig – with Health Minister Nina Warken and topics like AI, fee regulation, and abortion on the agenda.
Hope for Pulmonary Fibrosis Patients: New Drug Candidate Emerges
With Nerandomilast, Boehringer Ingelheim presents a groundbreaking drug candidate that could transform the treatment of pulmonary fibrosis. Phase III studies show first positive results in over a decade.
Court Overturns Ruling: FOCUS Doctor Seals Remain Valid
The Munich court has overturned the ban on FOCUS doctor seals—recommended physicians may continue to display their distinction publicly.